Literature DB >> 10844611

Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult.

K A Nath1, A J Croatt, J J Haggard, J P Grande.   

Abstract

BACKGROUND: Renal diseases are conventionally classified into acute and chronic disorders. We questioned whether acute, reversible, renal insults may be induced to incite a chronic scarring process, employing as an acute insult the glycerol model of heme protein-induced renal injury.
METHODS: Rats were subjected to weekly injections of hypertonic glycerol for up to six months. Renal function was serially determined, and the effect of such insults on renal histology and renal expression of collagen and fibrogenic cytokines was assessed.
RESULTS: After the first injection of glycerol, which, expectedly, induced a prompt fall in the glomerular filtration rate (GFR), subsequent injections encountered a remarkable renal resistance in that the fall in GFR was markedly blunted. This resistance to acute decline in renal function in rats subjected to repetitive injections of glycerol was accompanied by less necrosis and apoptosis of renal tubular epithelial cells after such injections. The attenuation in the fall in GFR in response to repetitive exposure to glycerol-induced heme protein injury was maintained for up to six months. A progressive decline in GFR appeared after three months and was accompanied by histologic tubulointerstitial injury, the latter assessed at six months. These kidneys demonstrated up-regulation of collagen I, III, and IV in conjunction with increased expression of the oxidant-inducible, chemotactic cytokine, monocyte chemoattractant protein-1 (MCP-1), and the oxidant-inducible, fibrogenic cytokine, transforming growth factor-beta1 (TGF-beta1). The exposure of the kidney to a single injection of hypertonic glycerol increased the expression of both cytokines some three to five days following this exposure, while the exposure of NRK 49F cells in culture to an iron-dependent model of oxidative stress also increased expression of TGF-beta1 and collagen mRNAs.
CONCLUSIONS: We conclude that this nephrotoxic insult, repetitively administered, encounters a resistance in the kidney such that the expected fall in GFR does not occur. However, with time, such resistance is accompanied by a decrease in GFR, the latter associated with chronic tubulointerstitial disease. Thus, a long-term cost is exacted, either along with, or as a consequence of, such resistance. We suggest that chronic up-regulation of such oxidant-inducible genes such as TGF-beta1 and MCP-1 contributes to tubulointerstitial disease, and iron-mediated oxidative stress may directly induce TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844611     DOI: 10.1046/j.1523-1755.2000.00101.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  40 in total

1.  PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.

Authors:  Rongpei Lan; Hui Geng; Aaron J Polichnowski; Prajjal K Singha; Pothana Saikumar; Donald G McEwen; Karen A Griffin; Robert Koesters; Joel M Weinberg; Anil K Bidani; Wilhelm Kriz; Manjeri A Venkatachalam
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

2.  Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.

Authors:  Ali C M Johnson; Kirsten Becker; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-26

Review 3.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

4.  Induction of heme oxygenase-1 and ferritin in the kidney in warm antibody hemolytic anemia.

Authors:  Fernando C Fervenza; Anthony J Croatt; Camila M Bittar; David W Rosenthal; Donna J Lager; Nelson Leung; Steven R Zeldenrust; Karl A Nath
Journal:  Am J Kidney Dis       Date:  2008-09-21       Impact factor: 8.860

Review 5.  Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

Authors:  Manjeri A Venkatachalam; Joel M Weinberg; Wilhelm Kriz; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2015-03-25       Impact factor: 10.121

6.  Risk Factors for Recurrent Acute Kidney Injury in Children Who Undergo Multiple Cardiac Surgeries: A Retrospective Analysis.

Authors:  Denise C Hasson; John T Brinton; Ellen Cowherd; Danielle E Soranno; Katja M Gist
Journal:  Pediatr Crit Care Med       Date:  2019-07       Impact factor: 3.624

7.  Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.

Authors:  David P Basile; Joseph V Bonventre; Ravindra Mehta; Masaomi Nangaku; Robert Unwin; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-30       Impact factor: 10.121

Review 8.  Progression from acute kidney injury to chronic kidney disease: clinical and experimental insights and queries.

Authors:  Richard A Zager
Journal:  Nephron Clin Pract       Date:  2014-09-24

9.  Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI.

Authors:  Rajesh K Dutta; Vinay K Kondeti; Isha Sharma; Navdeep S Chandel; Susan E Quaggin; Yashpal S Kanwar
Journal:  J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 10.121

Review 10.  Pediatric acute kidney injury and the subsequent risk for chronic kidney disease: is there cause for alarm?

Authors:  Vaka K Sigurjonsdottir; Swasti Chaturvedi; Cherry Mammen; Scott M Sutherland
Journal:  Pediatr Nephrol       Date:  2018-01-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.